Newport Beach, Calif.-based Hoag became the first hospital in the U.S. to offer EsoGuard testing. The test is used by physicians to detect precancerous DNA changes in esophageal cells, helping to ...

People who use GLP-1 weight loss drugs like Ozempic are more likely to suffer from severe acid reflux, or GERD, a new ...

A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists ...

As technology continues to evolve, bringing AI, advanced imaging, and novel sampling techniques into routine practice, the ...

Key Takeaways GLP-1 drugs might increase a person’s risk of severe acid refluxPeople with type 2 diabetes taking GLP-1 drugs ...

Three senators introduced a resolution compelling the Philippine government to advocate for the interim release of former ...

TissueCypher is a laboratory test that can help predict the risk of developing esophageal cancer in patients diagnosed with Barrett’s esophagus (BE).

A capsule-sponge test may help identify patients with Barrett’s esophagus who are at low risk for dysplasia or esophageal ...

Discover the new EsoGuard test, touted as a non-invasive method for early detection of esophageal cancer that offers hope for ...

This year, more than 22,000 Americans face a chilling diagnosis: esophageal cancer. Men are 3 to 4 times more likely to ...

More than 22,000 Americans are diagnosed with esophageal cancer this year, with men being three to four times more likely to ...

A new esophageal cancer test helps patients detect precancerous conditions early and avoid invasive procedures.